Slovak Republic
Global Fin Swe Nor Den Ger Cze Svk Pol Hun USA
  • Logo
  • Produkty
  • O nás
  • Novinky
  • Kontaktujte nás
  • Sustainability
  • Aidian Academy
  • Antimikrobiálna rezistencia
Vyhľadávanie
Logo
  • COVID-19
    • Testy COVID-19
      • Aidian LF SARS-CoV-2 Ag Test
      • Biosynex COVID-19 Ag Test
      • ACRO™ Biotech 2019-nCoV IgG/IgM rýchly test
      • Qlife – egoo.health system
  • POCT
    • QuikRead go
      • QuikRead go Instrument
      • QuikRead go easy CRP
      • QuikRead go CRP
      • QuikRead go CRP+Hb
      • QuikRead go wrCRP
      • QuikRead go wrCRP+Hb
      • QuikRead go HbA1c
      • QuikRead go Strep A
      • QuikRead go iFOBT
      • QuikRead go príslušenstvo
    • Antimikrobiálna rezistencia a CRP
    • QuikRead 101
    • Aidian LF
    • Qlife – egoo.health system
    • ACRO™ Biotech
    • Biosynex
    • microINR
    • LabPad®
  • Monitorovanie hygieny
    • Easicult
    • Hygicult
  • Mikrobiológia
    • Uricult
    • Meridian Immunoassays
    • Meridian Curian®
  • Hematológia
    • Meridian LeadCare®
  • Molekulárna mikrobiológia
    • Meridian Revogene®
    • Meridian Alethia®
  • Iný
    • Grifols Promonitor®
Logo
Zavrieť
  • Produkty
    • COVID-19
      • Testy COVID-19
        • Aidian LF SARS-CoV-2 Ag Test
        • Biosynex COVID-19 Ag Test
        • ACRO™ Biotech 2019-nCoV IgG/IgM rýchly test
        • Qlife – egoo.health system
    • POCT
      • QuikRead go
        • QuikRead go Instrument
        • QuikRead go easy CRP
        • QuikRead go CRP
        • QuikRead go CRP+Hb
        • QuikRead go wrCRP
        • QuikRead go wrCRP+Hb
        • QuikRead go HbA1c
        • QuikRead go Strep A
        • QuikRead go iFOBT
        • QuikRead go príslušenstvo
      • Antimikrobiálna rezistencia a CRP
      • QuikRead 101
      • Aidian LF
      • Qlife – egoo.health system
      • ACRO™ Biotech
      • Biosynex
      • microINR
      • LabPad®
    • Monitorovanie hygieny
      • Easicult
      • Hygicult
    • Mikrobiológia
      • Uricult
      • Meridian Immunoassays
      • Meridian Curian®
    • Hematológia
      • Meridian LeadCare®
    • Molekulárna mikrobiológia
      • Meridian Revogene®
      • Meridian Alethia®
    • Iný
      • Grifols Promonitor®
  • O nás
  • Novinky
  • Kontaktujte nás
  • Sustainability
  • Aidian Academy
  • Antimikrobiálna rezistencia

Navrhované témy

antibiotic resistance CRP point-of-care

Obľúbené produkty

Tsmart®

Tsmart®

Ksmart®

Ksmart®

LabPad® Evolution

LabPad® Evolution

Najnovšie správy

Zobraziť všetko

How CRP point of care testing aids primary care and guides sustainable use of antibiotics

1. júna 2022 | Novinky, AMR

IVDR entered into application on 26 May 2022

31. mája 2022 | Novinky, Novinky o produktoch

Investment company Ferd will come as a co-owner of Aidian together with Nordstjernan

2. mája 2022 | Novinky

  • Zobraziť všetko
  • Neboli nájdené žiadne výsledky
  • Loading...

Správy

How CRP point of care testing aids primary care and guides sustainable use of antibiotics

1. júna 2022 | Novinky, AMR

IVDR entered into application on 26 May 2022

31. mája 2022 | Novinky, Novinky o produktoch

Späť na všetky novinky
15. decembra 2020
Novinky,
COVID-19

Antigen testing and CRP can help to low COVID-burden in elderly care.

The elderly living in long term care facilities are the most vulnerable for COVID-19. They have high probability of SARS-CoV-2 infection and a very high impact of disease.1 Estimated number of such facilities in EU/EEA and UK is 62000 with about 3,5 million inhabitants.2

Reducing virus transmission in long term care facilities by rapid antigen testing

Delayed diagnosis allows virus transmission among both healthcare personnel and the residents in long term care facilities.1,3. Also, early identification of SARS-CoV-2 is important on personal level.1 Elderly residents may have atypical symptoms of COVID-19, they may remain asymptomatic or develop symptoms later.4,5 Antigen tests are valuable tools because they provide quick results at the patient’s location. EU, ECDC and CDC all recommend rapid antigen testing for both staff and residents as one way of infection control in this setting.1,3,6 The tests are considered beneficial in both high and low prevalence situations – and even for asymptomatic persons during the pandemic.3,6

ECDC states that rapid antigen tests are easy to use, give quick results and have generally low cost.1 They enable prompt decisions and recurrent testing (even every 2-3 days) of both staff and residents to detect the infection early. The benefit is timely management of outbreak, as summarized by ECDC and European Commission.1,6

Check our antigen testing solutions here: https://www.aidian.eu/latest-c...

How CRP works in the elderly during COVID-19

CRP levels in the elderly suffering from COVID-19 seem to strongly reflect the disease severity and CRP can predict the outcome of the patient.7-12 Moreover, compared to younger COVID-19 patients, the elderly has higher risk of bacterial co-infections affecting mortality and CRP levels.12-14

Point of care CRP in long term facilities complements pathogen-specific testing by quickly directing towards the next steps. For positive antigen test results, CRP can identify COVID-19 patients developing the severe disease format. This may save lives by timely focusing special care resources on the patients that need it the most. For negative results, CRP may reveal underlying respiratory infection of bacterial origin - Community-acquired pneumonia (CAP) caused by other pathogens has not vanished!8

Find out about easy point of care CRP testing with QuikRead go: https://www.aidian.eu/point-of...

References:

1. ECDC, Rapid risk assessment. Available from: https://www.ecdc.europa.eu/sit..., 19.11.2020, accessed 9.12.2020

2. ECDC, Surveillance of COVID-19 at long-term care facilities in the EU/EEA. Available from: https://www.ecdc.europa.eu/en/..., updated 19.5.2020, Accessed 9.12.2020

3. CDC, Considerations for Use of SARS-CoV-2 Antigen Testing in Nursing Homes. Available from: https://www.cdc.gov/coronaviru..., updated 23.10.2020, accessed 9.12.2020

4. Yu C, Zhou M, Liu Y et al. Characteristics of asymptomatic COVID-19 infection and progression: A multicenter, retrospective study. Virulence. 2020; 11(1): 1006–1014. doi: 10.1080/21505594.2020.1802194

5. Mori H, Obinata H, Murakami W, et al. Comparison of COVID-19 disease between young and elderly patients: Hidden viral shedding of COVID-19. J Infect Chemother. 2021 Jan; 27(1): 70–75. doi: 10.1016/j.jiac.2020.09.003

6. European Commission. Commission Recommendation of 18.11.2020 on the use of rapid antigen tests for the diagnosis of SARS-CoV-2 infection. Available from: https://ec.europa.eu/health/si..., accessed 9.12.2020

7. Liu K, Chen Y, Lin R et al. Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients. J Infect. 2020; 80(6):e14-e18. doi: 10.1016/j.jinf.2020.03.005

8. Zhou Y, Guo S, He Y, et al. COVID-19 Is Distinct From SARS-CoV-2-Negative Community-Acquired Pneumonia. Front Cell Infect Microbiol. 2020; 10: 322. doi: 10.3389/fcimb.2020.00322

9. Gao S, Jiang F, Jin W, et al. Risk factors influencing the prognosis of elderly patients infected with COVID-19: a clinical retrospective study in Wuhan, China. Aging (Albany NY). 2020; 12(13): 12504–12516. doi: 10.18632/aging.103631

10. Covino M, De Matteis G, Santoro M, et al. Clinical characteristics and prognostic factors in COVID‐19 patients aged ≥80 years. Geriatr Gerontol Int. 2020; 10.1111/ggi.13960.

11. Hwang J et al. Prognostic Factors of COVID-19 Infection in Elderly Patients: A Multicenter Study. J. Clin. Med. 2020; 9(12), 3932; https://doi.org/10.3390/jcm912...

12. Wang L, He W, Yu X et al. Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up. J Infect. 2020; 80(6):639-645. doi: 10.1016/j.jinf.2020.03.019

13. Ruan Q, Yang K, Wang L et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020; 46(5):846-848. doi: 10.1007/s00134-020-05991-x

14. Huang C, Wang Y, Li X et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395: 497–506. https://doi.org/10.1016/ S0140-6736(20)30183-5






Share
Facebook
Twitter
Email

Aidian Oy

Bělohorská 57,
169 00 Praha 6,
Česká republika

+421 944 313 888

Fakturačné adresy

IČ DPH 45769842

  • Kontaktujte nás
  • Aidian Academy
  • Kariéra
  • Sustainability
  • Ochrana dát
    • Politika ochrany údajov
    • Vyhlásenie o ochrane súkromia
    • Zásady používania súborov cookie
    • Zásady pre používanie sociálnych sietí
    • Zákaz súhlas s priamym marketingom
  • Produkty
    • Testy COVID-19
    • QuikRead go
    • QuikRead
    • Aidian LF
    • Hygicult
    • Easicult
    • Uricult
    • Qlife
    • LabPad®
    • Biosynex
    • ACRO™ Biotech
    • microINR
    • Meridian Immunoassays
    • Meridian Curian®
    • Meridian LeadCare®
    • Meridian Revogene®
    • Meridian Alethia®
    • Grifols Promonitor®
Copyright © 2022 Aidian

Táto webová stránka používa cookies

Cookies používame na personalizáciu obsahu a reklám, na analýzu návštevnosti stránok a k zlepšovaniu našich služieb.

Spravovať

Nevyhnutné (povinný) (Požadovaný)

Tieto cookies sú nevyhnutné pre správne fungovanie stránok. Toto zahŕňa cookies pre prístup do zabezpečených oblastí a CSRF zabezpečenia. Upozorňujeme, že východiskové súbory cookies spoločnosti Craft nezhromažďujú žiadne osobné ani citlivé informácie. Craft predvolené súbory cookies nezhromažďujú IP adresy. Informácie, ktoré ukladajú, sa neposielajú spoločnostiam Pixel & Tonic ani žiadnym tretím stranám.
— CraftSessionId
Provider: this site
Expiration: Session
Description: Craft sa pri udržiavaní relácií naprieč webovým rozhraním spolieha na relácie PHP. To sa vykonáva pomocou cookie relácie PHP. Predvolené nastavenie Craft pomenováva tieto cookie ako "CraftSessionId", ale môžu byť premenované pomocou konfiguračného nastavenia phpSessionId. Platnosť cookie skončí, akonáhle vyprší platnosť relácie.
— *_identity
Provider: this site
Expiration: Persistent
Description: Keď sa prihlásite do ovládacieho panelu, dostanete overovací súbor cookie, ktorý sa používa na udržanie vášho overeného stavu. Názov cookie má predponu s dlhým, náhodne generovaným reťazcom, za ktorým nasleduje _identity. Súbor cookie ukladá iba informácie potrebné na udržanie zabezpečenej, overenej relácie a bude existovať len tak dlho, kým bude používateľ autorizovaný v Craft.
— *_username
Provider: this site
Expiration: Persistent
Description: Ak počas prihlásenia zaškrtnete možnosť "Ponechať ma prihláseného", používa sa tento súbor cookie na zapamätanie mena používateľa pre vaše ďalšie overenie.
— CRAFT_CSRF_TOKEN
Provider: this site
Expiration: Session
Description: Chráni nás i vás ako používateľa pred útokmi falšovania webových stránok (CSRF).

Štatistiky

Štatistické súbory cookies nám pomáhajú vďaka anonymnému zhromažďovaniu a hláseniu informácií porozumieť, ako sa návštevníci a webové stránky vzájomne ovplyvňujú.

Marketing

Marketingové cookies sú používané na sledovanie návštevníkov naprieč webovými stránkami. Zámerom je zobrazovať reklamy, ktoré sú relevantné a pútavé pre jednotlivého používateľa, a tým cennejšie pre vydavateľov a inzerentov tretích strán.
Skryť podrobnosti